Vanessa Carle
CIK: 0001855763
Transaction Breakdown
Open Market Buys (P)1 (50.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)1 (50.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
LEXX
Lexaria Bioscience Corp.
Officer
Discretionary Trading P&L
Holdings
About Carle Vanessa
Carle Vanessa (SEC CIK 0001855763) files insider reports with the SEC as Secretary of Lexaria Bioscience Corp. (LEXX).
Signal8 holds 2 ownership filings by Carle Vanessa, all Form 4s, filed between May 16, 2025 and Jul 30, 2025. Those filings report 2 transactions, from May 15, 2025 to Jul 29, 2025. Signal8's Form 4 history starts in Sep 2024.
The business address on Carle Vanessa's filings is in KELOWNA, A1.
Recent filings by Carle Vanessa
Other insiders filing for Lexaria Bioscience Corp. (LEXX)
- BUNKA CHRISTOPHER, Director
- DOCHERTY JOHN MARTIN, President
- CHRISTOPHER RICHARD, Chief Executive Officer
- Shankman Michael Elliot, Chief Financial Officer
- Bhullar Baljinder, Director
- Baxter Nicholas W, Director